Clinical Trial

Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children

Study acronym: MOMENTUM
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The overall objective of this study is to investigate the impact of early model-informed precision dosing (MIPD) on target attainment of three beta-lactam antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam and meropenem) in critically ill children. This evaluation includes a comparison with the more standard approach on clinical and patient-oriented measures.
Trial Details
NCT Number NCT06929702
Lead Sponsor University Hospital, Ghent
Conditions Amoxicillin-clavulanate, Piperacillin-tazobactam, Meropenem
Enrollment 58 participants
Start Date 2025-04-22
Primary Completion 2027-10-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-16